These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32566062)

  • 21. Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study.
    Villarroel PG; Padró JG; Marquina G; Jáñez NM; González EE; Antón A; Sánchez MB; Cáceres AR; López-López R; Cornejo RE; García PB; Fabregat RM; Fernández BC; Bermudo CL; Camps C
    Future Oncol; 2022 Nov; 18(35):3913-3927. PubMed ID: 36537885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
    Mercadante S; Caraceni A; Masedu F; Scipioni T; Aielli F
    Oncologist; 2020 Feb; 25(2):156-160. PubMed ID: 31862860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge and practice of the management of breakthrough cancer pain among general practitioners providing palliative care in Shanghai, China: a cross-sectional survey.
    Yu Y; Zhang P; Chen D; Jiang SF
    BMJ Open; 2023 Sep; 13(9):e073670. PubMed ID: 37770268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practice Patterns in Distinguishing Between Background Pain and Breakthrough Pain During Patient Education: a Korean Physician Survey.
    Shin J; Kim DY; Lee J; Choi YS; Hwang IG; Baek SK; Seo MS; Shim JY
    J Cancer Educ; 2018 Apr; 33(2):284-292. PubMed ID: 27623849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials.
    Jandhyala R; Fullarton JR; Bennett MI
    J Pain Symptom Manage; 2013 Oct; 46(4):573-80. PubMed ID: 23380337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a theory-driven educational intervention on the level of knowledge, attitudes, and assessment practices regarding breakthrough cancer pain (BTCP) management among medical nurses in Hong Kong.
    Kwok CYL; Chan DNS; So WKW
    Eur J Oncol Nurs; 2021 Jun; 52():101945. PubMed ID: 33813183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthrough pain in patients with abdominal cancer pain.
    Mercadante S; Adile C; Giarratano A; Casuccio A
    Clin J Pain; 2014 Jun; 30(6):510-4. PubMed ID: 24281289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breakthrough Cancer Pain: Ten Commandments.
    Mercadante S; Cuomo A
    Value Health; 2016; 19(5):531-6. PubMed ID: 27565269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription.
    Villegas Estévez F; López Alarcón MD; Alonso Babarro A; Olay Gayoso L; de Castro J; Lería-Gelabert M; Melogno-Klinkas M
    Curr Med Res Opin; 2020 Aug; 36(8):1383-1391. PubMed ID: 32453602
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies.
    Mercadante S; Valle A; Porzio G; Aielli F; Adile C; Ficorella C; Raineri M; Giarratano A; Casuccio A
    Curr Med Res Opin; 2013 Jun; 29(6):667-71. PubMed ID: 23551065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the Amharic Version of the Brief Pain Inventory for Utility in Ethiopian Cancer Patients.
    Anshabo AT; Migbaru S; Awoke D; Tigeneh W; Engidawork E
    Pain Pract; 2017 Nov; 17(8):1023-1031. PubMed ID: 28117554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adequacy of cancer-related pain management and predictors of undertreatment at referral to a pain clinic.
    Reis-Pina P; Lawlor PG; Barbosa A
    J Pain Res; 2017; 10():2097-2107. PubMed ID: 28919809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Observational Research Study to Evaluate the Impact of Breakthrough Cancer Pain on the Daily Lives and Functional Status of Patients.
    Twomey F; O'Brien T; O'Reilly M; Bogan C; Fleming J
    Ir Med J; 2015 Jun; 108(6):174-6. PubMed ID: 26182800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study.
    Boceta J; De la Torre A; Samper D; Farto M; Sánchez-de la Rosa R
    Clin Transl Oncol; 2016 Nov; 18(11):1088-1097. PubMed ID: 26856600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and characterization of breakthrough pain in patients with cancer in Spain: the CARPE-DIO study.
    Pérez-Hernández C; Blasco A; Gándara Á; Mañas A; Rodríguez-López MJ; Martínez V; Fernandez-Nistal A; Montoto C
    Sci Rep; 2019 Nov; 9(1):17701. PubMed ID: 31776408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment.
    Cortesi PA; D'Angiolella LS; Vellucci R; Allegri M; Casale G; Favaretti C; Kheiraoui F; Cesana G; Mantovani LG
    PLoS One; 2017; 12(6):e0179523. PubMed ID: 28654672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current management of breakthrough cancer pain according to physicians from pain units in Spain.
    Estévez FV; Alarcón MDL; Mayoral V; de Madariaga M; Margarit C; Duran JA; Martín-Arroyo JMT; Carregal A;
    Clin Transl Oncol; 2019 Sep; 21(9):1168-1176. PubMed ID: 30783918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How nurses assess breakthrough cancer pain, and the impact of this pain on patients' daily lives--results of a European survey.
    Rustøen T; Geerling JI; Pappa T; Rundström C; Weisse I; Williams SC; Zavratnik B; Wengström Y
    Eur J Oncol Nurs; 2013 Aug; 17(4):402-7. PubMed ID: 23276599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved patient functioning after treatment of breakthrough cancer pain: an open-label study of fentanyl buccal tablet in patients with cancer pain.
    Davies A; Kleeberg UR; Jarosz J; Mercadante S; Poulain P; O'Brien T; Schneid H; Kress HG
    Support Care Cancer; 2015 Jul; 23(7):2135-43. PubMed ID: 25556611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of fentanyl pectin nasal citrate in controlling episodes of breakthrough cancer pain triggered by routine radiotherapy procedures.
    Pardo J; Mena A; Jiménez E; Aymar N; Ortiz I; Roncero R; Mestre F; Vidal M
    Clin Transl Oncol; 2019 Nov; 21(11):1568-1572. PubMed ID: 31093890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.